Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


Articles published in PLoS Biol

Retrieve available abstracts of 7 articles:
HTML format



Single Articles


    May 2022
  1. MAMAIS A, Kluss JH, Bonet-Ponce L, Landeck N, et al
    Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
    PLoS Biol. 2022;20:e3001621.
    PubMed     Abstract available


    March 2022
  2. BERARD M, Sheta R, Malvaut S, Rodriguez-Aller R, et al
    A light-inducible protein clustering system for in vivo analysis of alpha-synuclein aggregation in Parkinson disease.
    PLoS Biol. 2022;20:e3001578.
    PubMed     Abstract available


    December 2021
  3. MAMAIS A, Kluss JH, Bonet-Ponce L, Landeck N, et al
    Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
    PLoS Biol. 2021;19:e3001480.
    PubMed     Abstract available


    July 2021
  4. RAJASEKARAN S, Witt SN
    Trojan horses and tunneling nanotubes enable alpha-synuclein pathology to spread in Parkinson disease.
    PLoS Biol. 2021;19:e3001331.
    PubMed     Abstract available


    November 2019
  5. ZHENG YQ, Zhang Y, Yau Y, Zeighami Y, et al
    Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation.
    PLoS Biol. 2019;17:e3000495.
    PubMed     Abstract available


    June 2019
  6. WU S, Tan KJ, Govindarajan LN, Stewart JC, et al
    Fully automated leg tracking of Drosophila neurodegeneration models reveals distinct conserved movement signatures.
    PLoS Biol. 2019;17:e3000346.
    PubMed     Abstract available


  7. BIROL M, Wojcik SP, Miranker AD, Rhoades E, et al
    Identification of N-linked glycans as specific mediators of neuronal uptake of acetylated alpha-Synuclein.
    PLoS Biol. 2019;17:e3000318.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: